24 March 2017
News and Views
Links and Services
Chromogranin A as a biomarker of disease activity and biologic therapy in inflammatory bowel disease, reports the most recent issue of the Scandanavian Journal of Gastroenterology.
Dr Stergios Vradelis and colleagues assessed the correlation of Chromogranin A (
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors